Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
PHASE4CompletedINTERVENTIONAL
Enrollment
53
Participants
Timeline
Start Date
May 31, 2005
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Conditions
Myotoxicity of Atorvastatin Treatment
Interventions
DRUG
Atorvastatin
20 to 80 mg per day
Trial Locations (1)
0027
Rikshospitalet-Radiumhospitalet HF, Lipid clinic, Oslo
All Listed Sponsors
lead
University of Oslo School of Pharmacy
OTHER
NCT00414531 - Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity | Biotech Hunter | Biotech Hunter